Newspaper publication for Audited Financial Results.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech Ltd has submitted copies of newspaper advertisements published on May 21, 2025, in Financial Express (English) and Nava Telangana (Telugu), containing its audited financial results for the fourth quarter and full year ended March 31, 2025. The filing is made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015, and was signed by Company Secretary Vaishnavi Kiran Ayinampudi. This is a routine regulatory disclosure confirming that the already-audited results were also published in newspapers as required. The detailed numerical figures referenced in the advertisement are not clearly readable in the document image provided.
This is a procedural compliance filing, not a new financial announcement. No fresh price-moving information is being shared — the audited Q4 and FY25 results would have been filed separately with the exchanges earlier. Shareholders should look to the original results filing for actual revenue, profit, and EPS data.